查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104509

生物製藥塑膠市場：依材料、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Biopharma Plastic Market, By Material Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 328 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，生物製藥塑膠市場價值將達到 75.16 億美元，並將在 2026 年至 2033 年期間以 7.9% 的複合年成長率成長。

生物製藥塑膠是專為生物製藥生產、藥物研發、實驗室研究和醫療應用而設計的高級聚合物材料。這些材料包括聚乙烯 (PE)、聚丙烯 (PP)、聚對苯二甲酸乙二醇酯 (PET)、聚氯乙烯(PVC)、丙烯腈-丁二烯-苯乙烯共聚物 (ABS) 和聚碳酸酯 (PC) 等聚合物，它們被用於生物反應器袋、瓶和其他個人防護設備。

受一次性生物製程設備使用量增加、生物製藥生產規模擴大、生技藥品和細胞/基因療法需求成長以及疫苗生產投資等因素的推動，該市場正經歷強勁成長。醫用聚合物的進步和創新的生物製程解決方案進一步促進了市場成長，而醫療和生物製藥製造領域支出的增加則推動了市場滲透率的提升。

生物製藥塑膠市場－市場動態

生物製藥生產領域投資的增加正在推動市場成長。

生物製藥製造業的投資增加是推動生物製藥塑膠市場成長的關鍵因素。政府機構和私人公司正增加對生技藥品、疫苗、生物相似藥、細胞和基因療法以及生物製藥設施的投資，以改善醫療保健系統的基礎設施並增強藥品供應鏈的韌性。這一趨勢推動了對高階生物製藥塑膠的需求，這些塑膠廣泛應用於一次性生物反應器系統、流體控制系統、包裝材料、注射器、一次性連接器和無菌包裝解決方案。與傳統技術相比，這些產品具有更優異的生物相容性、耐化學性、無菌性和污染控制能力，同時還能減少清潔工作量和營運成本。

根據印度新聞資訊局（PIB）消息，2026-2027會計年度擬議預算包括推出一項名為「生物製藥力量」（Biopharma SHAKTI）的新舉措，該計劃將在五年內投資1000億盧比，以加強印度生技藥品和生物類似藥的生產生態系統。預計該舉措將增加對用於生物製程、一次性技術、藥品包裝和藥物傳輸系統的生物製藥塑膠的需求。因此，全球生物製藥產能的持續擴張和一次性生物生物製程系統的進步預計將在整個預測期內推動生物製藥塑膠市場的持續成長。

生物製藥塑膠市場－市場區隔分析：

全球生物製藥塑膠市場按材料類型、應用、最終用戶和地區進行細分。

在生物製藥塑膠市場，聚丙烯 (PP) 因其優異的耐化學性、熱穩定性、低萃取率以及與伽馬射線輻照和高壓釜滅菌等滅菌技術的兼容性而佔據顯著的市場佔有率。由於其良好的生物相容性和已獲監管部門批准，這種材料被廣泛應用於一次性生物製程系統、生物反應器、實驗室燒瓶、注射器、流體傳輸組件和藥品包裝。例如，2025 年 1 月，蕭特製藥 (SCHOTT Pharma) 發布了 SCHOTT TOPPAC® 輸注聚合物注射器系統，旨在提高生物製藥和其他敏感藥物給藥的安全性、效率和永續性。這款先進的聚合物注射器系統具有高抗破損性、低矽油含量以及與精細配方的兼容性，有助於無菌填充和表面處理工程。這進一步證明了聚合物解決方案在生物製藥生產和給藥領域的應用日益廣泛。同時，由於 PE 和 PC 在生物反應器袋、管道、流體管理系統和一次性生物製程組件等領域有著廣泛的應用，因此預計它們將繼續保持較高的需求量。

按應用領域分類，生物反應器袋類產品是市場成長的主要驅動力，這主要得益於生物製藥、疫苗和細胞治療產品生產中一次性生物製程解決方案的快速普及。其他應用領域，例如容器、注射器、深度過濾器、防護衣和一次性醫用連接器，也佔據了相當大的市場佔有率，反映了製藥生產中一次性技術的日益普及趨勢。按終端用戶分類，生物製藥公司佔據了大部分市場佔有率，這主要得益於其在生物製藥、疫苗和先進療法生產方面的投資增加。契約製造生產商 (CMO) 預計將實現最高的成長率，這主要受生物製藥生產外包業務不斷成長的推動。

生物製藥塑膠市場—區域分析

北美憑藉其成熟的生物製藥產業、對生物製藥生產的大量投資以及一次性生物製程解決方案的廣泛應用，在生物製藥塑膠市場佔據主導地位。推動這一成長的關鍵因素包括生物製藥公司、合約生產組織（CMO）和研究中心等領先企業的存在。美國食品藥物管理局（FDA）預計，其藥品評估與研究中心（CDER）將在2024年批准50種新藥，凸顯了生物製藥和特種藥物產業的持續發展。隨著先進療法的商業化程度不斷提高以及對生物製造工廠投資的增加，用於生物反應器、流體管理系統、注射器和無菌包裝解決方案的塑膠需求也在不斷成長。

歐洲也是一個重要的市場，這得益於其強大的製藥生產基礎設施、前瞻性的監管政策以及對生物製藥生產設施不斷成長的投資。根據歐洲製藥工業協會（EFPIA）統計，到2024年，歐洲製藥業在研發方面的投資金額約為550億歐元，這反映了該地區致力於開發和生產創新藥物的決心。對生物製藥、生物相似藥以及細胞和基因療法的需求不斷成長，加上一次性生物製程技術的廣泛應用，正推動著歐洲製藥生產和研發領域對高性能生物製藥塑膠的需求持續成長。

目錄

第1章：生物製藥塑膠市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：生物製藥塑膠的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：生物製藥塑膠產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：生物製藥塑膠市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：生物製藥塑膠市場趨勢

  • 生物製藥塑膠市場佔有率分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：生物製藥塑膠市場：依材料類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按材料類型
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚對苯二甲酸乙二醇酯（PET）
    • 聚氯乙烯（PVC）
    • 丙烯腈丁二烯苯乙烯（ABS）
    • 聚碳酸酯（PC）
    • 其他

第8章：生物製藥塑膠市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 生物反應器袋
    • 瓶子和容器
    • 注射器
    • 管材和連接器
    • 防護衣
    • 一次組裝
    • 其他

第9章：生物製藥塑膠市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 生物製藥公司
    • 契約製造公司（CMO）
    • 研究機構和大學
    • 醫院和診所
    • 其他

第10章：生物製藥塑膠市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：生物製藥塑膠產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Pall Corporation
    • Repligen Corporation
    • Sartorius AG
    • Merck KGaA
    • Danaher Corporation（Cytiva）
    • Avantor, Inc.
    • Corning Incorporated
    • Saint-Gobain Life Sciences
    • SCHOTT Pharma AG & Co. KGaA
    • West Pharmaceutical Services, Inc.
    • DWK Life Sciences
    • Entegris, Inc.
    • Freudenberg Medical
    • TekniPlex Healthcare
    • Nipro Corporation
    • Gerresheimer AG
    • AptarGroup, Inc.
    • Becton, Dickinson and Company（BD）
    • Terumo Corporation
    • Asahi Kasei Corporation
    • Mitsubishi Chemical Group
    • Berry Global Group, Inc.
    • Rochling Medical
    • RENOLIT Healthcare
    • Nordson MEDICAL
    • DuPont
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7069

Biopharma Plastic Market size was valued at US$ 7,501.6 Million in 2025, expanding at a CAGR of 7.9% from 2026 to 2033.

Biopharma plastics are advanced polymer substances that have been specifically engineered to be employed in the manufacture of biopharmaceutical products, development of drugs, laboratory studies, and healthcare. They include polymers such as polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), polyvinyl chloride (PVC), acrylonitrile butadiene styrene (ABS), and polycarbonate (PC) that are used in bioreactor bags, bottles, syringes, depth filters, disposable connectors, and personal protective equipment owing to the excellent chemical resistance, sterility, biocompatibility, and compliance with regulations.

The market is experiencing robust growth on account of the rising utilization of single-use bioprocess equipment, expansion in the production of biopharmaceuticals, increasing need for biologics and cell & gene therapies, and investments in vaccine production. Advances in polymers for medical applications and innovative bioprocessing solutions are further catalyzing the market growth, while higher spending on healthcare and biopharmaceutical manufacturing is bolstering market adoption.

Biopharma Plastic Market- Market Dynamics

Increasing Investments in Biopharmaceutical Manufacturing Propel Market Growth

Growing investment in biopharmaceutical manufacturing industry is the significant driver for the rising market of Biopharma Plastics. Governmental agencies and private companies are increasing investments in the manufacturing of biologics, vaccines, biosimilars, cell and gene therapy drugs and biopharmaceutical facilities to improve the health care system infrastructure and increase the resiliency of pharmaceutical supply chains. Such a trend is leading to the increased demand for high-end biopharma plastics that are used in single-use bioreactor systems, fluid management systems, packaging materials, syringes, disposable connectors and sterile packaging solutions. These products provide good levels of biocompatibility, chemical resistance, sterility, and contamination control along with reduced cleaning needs and operating costs in comparison with conventional technology.

As per Press Information Bureau (PIB), the budget estimate for fiscal year 2026-27 included the launch of the new initiative of 'Biopharma SHAKTI' with a total outlay of ₹10,000 crore in five years to boost the ecosystem for manufacturing of biologics and biosimilars in India. This initiative is expected to increase the demand for biopharma plastics that are used in bioprocessing, single-use technology and pharmaceutical packaging and drug delivery systems. Consequently, the ongoing expansion of global biopharmaceutical manufacturing capacity and advancements in disposable bioprocessing systems are expected to drive sustained growth of the Biopharma Plastic Market throughout the forecast period.

Biopharma Plastic Market- Segmentation Analysis:

The Global Biopharma Plastic Market is segmented on the basis of Material Type, Application, End User, and Region.

In the Biopharma Plastic Market, in terms of material type, polypropylene (PP) represents a substantial market share due to its superior chemical resistance, thermal stability, low level of extractables, and compatibility with sterilization techniques like gamma irradiation and autoclaving. The material is widely employed in single use bioprocessing systems, bioreactors, laboratory flasks, syringes, fluid transfer components and pharmaceutical packaging due to high biocompatibility and regulatory approval. As an example, in January 2025, SCHOTT Pharma introduced SCHOTT TOPPAC(R) infuse polymer syringe system aimed at improving safety, efficiency and sustainability of the delivery of biologics and other sensitive pharmaceuticals. The highly advanced polymer syringe system features high break resistance, lower amounts of silicone oil and compatibility with sensitive formulations, which facilitates the aseptic filling and finishing process. This is another evidence of growing application of polymer solutions in the field of biologics manufacturing and delivery. At the same time, PE and PC continue to experience high demand due to their widespread application in bioreactor bags, tubing, fluid management systems, and disposable bioprocessing assemblies.

Based on Application, the Bioreactor Bags category dominates the market because of the swift adoption of single-use bioprocessing solutions for biologics, vaccine, and cell therapy manufacturing. The Containers, Syringes, Depth Filters, Protective Wear, and Disposable Medical Connectors are other application segments that have significant market shares since there is an increased tendency towards using disposable technology in the manufacture of pharmaceuticals. Based on End User, the segment of Biopharmaceutical Companies dominates the market share because of increased investments in the manufacturing of biologics, vaccines, and advanced therapies. CMOs are projected to record the highest growth driven by increasing outsourcing of biopharmaceutical production.

Biopharma Plastic Market- Geographical Insights

North America holds the dominant position in the Biopharma Plastic Market, due to an established biopharma industry, significant investments in biologics production, and the extensive use of single-use bioprocessing solutions. The key factors contributing to this growth include the presence of top players in biopharma companies, CMOs, and research centers. As per the U.S. Food and Drug Administration (FDA), the Center for Drug Evaluation and Research (CDER) has authorized 50 new drugs in 2024, which highlights continuous development in the biologics and specialty pharma industries. Increasing commercialization of advanced therapies, along with growing investments in biomanufacturing plants, is boosting the demand for plastics used in bioreactors, fluid management systems, syringes, and sterile packaging solutions.

Europe is also an important market due to its robust pharma manufacturing infrastructure, positive regulation policy, and growing investments in biologics manufacturing facilities. According to EFPIA (European Federation of Pharmaceutical Industries and Associations), the European pharmaceutical industry invests about €55.0 billion on R&D in 2024, showing the region's commitment to developing and manufacturing innovative pharmaceuticals. Growing requirements for biologics, biosimilar drugs, and cell & gene therapies coupled with the growing trend of using single-use bioprocess technologies keeps pushing forward the demand for high-performance biopharma plastics in pharmaceutical manufacturing and research in Europe.

Biopharma Plastic Market- Competitive Landscape:

The competitive landscape of the Biopharma Plastic Market is highly competitive as manufacturers of top players in the market concentrate on developing innovative medical-grade polymer products and single-use bioprocess solutions owing to the rising demand for biologics, vaccines, and advanced therapies. The key competitors in the market include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Avantor, Inc., Danaher Corporation (Cytiva), Corning Incorporated, Saint-Gobain Life Sciences, SCHOTT Pharma AG & Co. KGaA, DWK Life Sciences, and West Pharmaceutical Services, Inc. These companies compete in terms of innovations, expanding manufacturing capacities, collaborations, and investment in sustainable bioprocess technology. Innovations indicate that manufacturers in the market pay close attention to enhancing the performance of their products, sterility, and manufacturing capabilities along with satisfying the rising demand for disposable plastics in the production of biopharmaceuticals.

Recent Developments:

In December 2025, Thermo Fisher Scientific expanded its bioprocessing capabilities across Asia by opening a new Bioprocess Design Center in Hyderabad, India, and enlarging existing centers in South Korea and Singapore. The expansion strengthened regional support for biopharmaceutical manufacturers, enhancing biomanufacturing efficiency, technology access, and tailored process development capabilities.

In October 2024, Berry Global launched its ClariPPil(TM) clarified polypropylene (PP) bottles as a fully recyclable alternative to coloured PET pill bottles for healthcare applications. The new packaging solution offered improved sustainability, reduced carbon footprint, enhanced recyclability, superior product protection, and strong aesthetic appeal while supporting pharmaceutical packaging requirements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMA PLASTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • Pall Corporation
  • Repligen Corporation
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation (Cytiva)
  • Avantor, Inc.
  • Corning Incorporated
  • Saint-Gobain Life Sciences
  • SCHOTT Pharma AG & Co. KGaA
  • West Pharmaceutical Services, Inc.
  • DWK Life Sciences
  • Entegris, Inc.
  • Freudenberg Medical
  • TekniPlex Healthcare
  • Nipro Corporation
  • Gerresheimer AG
  • AptarGroup, Inc.
  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • Asahi Kasei Corporation
  • Mitsubishi Chemical Group
  • Berry Global Group, Inc.
  • Rochling Medical
  • RENOLIT Healthcare
  • Nordson MEDICAL
  • DuPont
  • Others

GLOBAL BIOPHARMA PLASTIC MARKET, BY MATERIAL TYPE - MARKET ANALYSIS, 2020 - 2033

  • Polyethylene (PE)
  • Polypropylene (PP)
  • Polyethylene Terephthalate (PET)
  • Polyvinyl Chloride (PVC)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Polycarbonate (PC)
  • Others

GLOBAL BIOPHARMA PLASTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Bioreactor Bags
  • Bottles & Containers
  • Syringes
  • Tubing & Connectors
  • Protective Wear
  • Single-Use Assemblies
  • Others

GLOBAL BIOPHARMA PLASTIC MARKET, BY END USER - MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Research Institutions and Universities
  • Hospitals and Clinics
  • Others

GLOBAL BIOPHARMA PLASTIC MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Biopharma Plastic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biopharma Plastic Market Snippet by Material Type
    • 2.1.2. Biopharma Plastic Market Snippet by Application
    • 2.1.3. Biopharma Plastic Market Snippet by End User
    • 2.1.4. Biopharma Plastic Market Snippet by Country
    • 2.1.5. Biopharma Plastic Market Snippet by Region
  • 2.2. Competitive Insights

3. Biopharma Plastic Key Market Trends

  • 3.1. Biopharma Plastic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biopharma Plastic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biopharma Plastic Market Opportunities
  • 3.4. Biopharma Plastic Market Future Trends

4. Biopharma Plastic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biopharma Plastic Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biopharma Plastic Market Landscape

  • 6.1. Biopharma Plastic Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biopharma Plastic Market - By Material Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material Type, 2025 & 2033 (%)
    • 7.1.2. Polyethylene (PE)
    • 7.1.3. Polypropylene (PP)
    • 7.1.4. Polyethylene Terephthalate (PET)
    • 7.1.5. Polyvinyl Chloride (PVC)
    • 7.1.6. Acrylonitrile Butadiene Styrene (ABS)
    • 7.1.7. Polycarbonate (PC)
    • 7.1.8. Others

8. Biopharma Plastic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Bioreactor Bags
    • 8.1.3. Bottles & Containers
    • 8.1.4. Syringes
    • 8.1.5. Tubing & Connectors
    • 8.1.6. Protective Wear
    • 8.1.7. Single-Use Assemblies
    • 8.1.8. Others

9. Biopharma Plastic Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Biopharmaceutical Companies
    • 9.1.3. Contract Manufacturing Organizations (CMOs)
    • 9.1.4. Research Institutions and Universities
    • 9.1.5. Hospitals and Clinics
    • 9.1.6. Others

10. Biopharma Plastic Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biopharma Plastic Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biopharma Plastic Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biopharma Plastic Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Biopharma Plastic Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Biopharma Plastic Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Material Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Biopharma Plastic Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Pall Corporation
    • 11.2.3. Repligen Corporation
    • 11.2.4. Sartorius AG
    • 11.2.5. Merck KGaA
    • 11.2.6. Danaher Corporation (Cytiva)
    • 11.2.7. Avantor, Inc.
    • 11.2.8. Corning Incorporated
    • 11.2.9. Saint-Gobain Life Sciences
    • 11.2.10. SCHOTT Pharma AG & Co. KGaA
    • 11.2.11. West Pharmaceutical Services, Inc.
    • 11.2.12. DWK Life Sciences
    • 11.2.13. Entegris, Inc.
    • 11.2.14. Freudenberg Medical
    • 11.2.15. TekniPlex Healthcare
    • 11.2.16. Nipro Corporation
    • 11.2.17. Gerresheimer AG
    • 11.2.18. AptarGroup, Inc.
    • 11.2.19. Becton, Dickinson and Company (BD)
    • 11.2.20. Terumo Corporation
    • 11.2.21. Asahi Kasei Corporation
    • 11.2.22. Mitsubishi Chemical Group
    • 11.2.23. Berry Global Group, Inc.
    • 11.2.24. Rochling Medical
    • 11.2.25. RENOLIT Healthcare
    • 11.2.26. Nordson MEDICAL
    • 11.2.27. DuPont
    • 11.2.28. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us